PET imaging and research, particularly in multiple myeloma; PET-CT in oncology; PET-CT in myocardial perfusion; SPECT-CT for myocardial perfusion with or without CT angiography; Graduate medical education in Nuclear Medicine, especially in PET-CT and CT


The following timeline graph is generated from all co-authored publications.

  1. Measured human dosimetry of 68Ga-DOTATATE. Walker RC, Smith GT, Liu E, Moore B, Clanton J, Stabin M (2013) J Nucl Med 54(6): 855-60
    › Primary publication · 23516312 (PubMed) · PMC4472480 (PubMed Central)
  2. [18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Ménétrier's disease. McKinley ET, Smith RA, Tanksley JP, Washington MK, Walker R, Coffey RJ, Manning HC (2012) Ann Nucl Med 26(9): 757-63
    › Primary publication · 22821337 (PubMed) · PMC3543701 (PubMed Central)
  3. Imaging of multiple myeloma and related plasma cell dyscrasias. Walker RC, Brown TL, Jones-Jackson LB, De Blanche L, Bartel T (2012) J Nucl Med 53(7): 1091-101
    › Primary publication · 22693310 (PubMed)
  4. Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease. Grogan EL, Weinstein JJ, Deppen SA, Putnam JB, Nesbitt JC, Lambright ES, Walker RC, Dittus RS, Massion PP (2011) J Thorac Oncol 6(10): 1720-5
    › Primary publication · 21760552 (PubMed) · PMC3712870 (PubMed Central)
  5. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Deppen S, Putnam JB, Andrade G, Speroff T, Nesbitt JC, Lambright ES, Massion PP, Walker R, Grogan EL (2011) Ann Thorac Surg 92(2): 428-32; discussion 433
    › Primary publication · 21592456 (PubMed) · PMC3186439 (PubMed Central)
  6. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Bartel TB, Haessler J, Brown TL, Shaughnessy JD, van Rhee F, Anaissie E, Alpe T, Angtuaco E, Walker R, Epstein J, Crowley J, Barlogie B (2009) Blood 114(10): 2068-76
    › Primary publication · 19443657 (PubMed) · PMC2744568 (PubMed Central)
  7. New imaging tools for the diagnosis of infection. Walker RC, Jones-Jackson LB, Martin W, Habibian MR, Delbeke D (2007) Future Microbiol 2(5): 527-54
    › Primary publication · 17927475 (PubMed)
  8. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. King DL, Stack BC, Spring PM, Walker R, Bodenner DL (2007) Otolaryngol Head Neck Surg 137(3): 400-4
    › Primary publication · 17765765 (PubMed)
  9. Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy JD, Epstein J, van Hemert R, Erdem E, Hoering A, Crowley J, Ferris E, Hollmig K, van Rhee F, Zangari M, Pineda-Roman M, Mohiuddin A, Yaccoby S, Sawyer J, Angtuaco EJ (2007) J Clin Oncol 25(9): 1121-8
    › Primary publication · 17296972 (PubMed)
  10. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Shaughnessy JD, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, Stewart JP, Kordsmeier B, Randolph C, Williams DR, Xiao Y, Xu H, Epstein J, Anaissie E, Krishna SG, Cottler-Fox M, Hollmig K, Mohiuddin A, Pineda-Roman M, Tricot G, van Rhee F, Sawyer J, Alsayed Y, Walker R, Zangari M, Crowley J, Barlogie B (2007) Blood 109(6): 2276-84
    › Primary publication · 17105813 (PubMed)